https://kuraoncology.com/wp-content/uploads/Troy_EOY.jpg5531030eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2025-06-23 13:59:592025-06-23 14:14:02Kura CEO Troy Wilson Named an EY Entrepreneur Of The Year® 2025 Pacific Southwest Award Winner
https://kuraoncology.com/wp-content/uploads/Kura-Video-LinkedIn-Article-Header.png6441200eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2025-05-02 13:00:042025-06-17 13:29:19Progress By Collaboration: The Development of Kura’s Menin Inhibitor for AML Research
https://kuraoncology.com/wp-content/uploads/Kura_BTOPEX.jpg366670eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2025-05-02 12:00:372025-06-17 13:54:37Achievement in Operational Excellence to Deliver Business Transformation
https://kuraoncology.com/wp-content/uploads/MedicineMaker.jpg366670eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2025-05-02 11:00:192025-06-17 13:26:40Asking the Right Questions in R&D
https://kuraoncology.com/wp-content/uploads/PharmaVoice.jpg366670eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2025-05-02 10:00:322025-06-17 13:26:44PharmaVoice’s Crystal Ball: Industry shifts in R&D, policy and clinical trials
https://kuraoncology.com/wp-content/uploads/ScripAsks5.jpg366670eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2025-05-02 09:00:172025-06-17 13:26:47Scrip Asks… What Does 2025 Hold For Biopharma? Part 5: Clinical Trials Trends
https://kuraoncology.com/wp-content/uploads/World_AML.jpg366670eallison/wp-content/uploads/kura-logo-registered-blue.svgeallison2025-04-17 11:00:372025-04-24 16:36:12AML World Awareness Day and Kura’s Commitment